ONCOLOGISTS’ BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY
Roberts MC, Bryson A, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes K, Wheeler SB. ONCOLOGISTS’ BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY. International Journal Of Technology Assessment In Health Care 2016, 32: 355-361. PMID: 27958190, PMCID: PMC6526532, DOI: 10.1017/s026646231600060x.Peer-Reviewed Original ResearchMeSH KeywordsAdultBiomarkers, TumorBreast NeoplasmsChemotherapy, AdjuvantFemaleGene Expression ProfilingHealth Knowledge, Attitudes, PracticeHumansInterviews as TopicMaleMiddle AgedOncologistsPrecision MedicineQualitative ResearchConceptsAdjuvant chemotherapy decisionsBreast cancer patientsOncotype DXTreatment decisionsCancer patientsChemotherapy decisionsHormone receptor-positive breast cancer patientsClinical practiceReceptor-positive breast cancer patientsPositive breast cancer patientsOncotype DX useUnited States guidelinesProfiling testsEligible womenSurgical oncologistsCancer careClinical guidelinesModifiable barriersOncologistsMulti-level factorsPatientsThematic saturationPhone interviewsIntermediate scoresQualitative study